プロフィール詳細

プロジェクトを作成

★★★★★

☆☆☆☆☆

★★★★★

☆☆☆☆☆

Dr. Ana K.に依頼

Serbia

PhD in Genetics; Genetic counselor; Expert in cancer genetics, Cancer research and Bioethics

プロフィール概要

Committed, determined and responsible molecular biologist with 10+ years of experience in cancer research and 5+ years of experience in clinical genetics and bioethics. I am experienced in interpretation of genomic data, variant annotation and genetic counseling. My core skills include wide array of laboratory techniques, experimental design, writing scientific papers and grant proposals. I have demonstrated an ability to manage and conduct both research and clinical laboratory projects. ACHIEVEMENTS o Established Department for genetic counseling at the Institute for Oncology and Radiology of Serbia o Incorporated next generation sequencing into routine clinical use for hereditary breast and ovarian cancer patients in Serbia o Published more than 30 scientific papers SKILLS o Pre and post test genetic counseling in cancer genetics o Performing informed consent process for research participants recruitment o Genomic data interpretation and variant annotation o Experienced in carrying out molecular laboratory work including high-throughput genomic technologies o Excellent verbal communication skills, delivery of presentations, lectures, seminars and tutorials. Skilled in work with students. o Excellent writing skills, publishing scientific papers and writing grant proposals

専門分野

• ★ Genetics
• ★ Medical Genetics
• ★ Medical Writing
• ☆ Molecular Biology
• ☆ Bioethics & Medical Ethics
• ☆ Cancer Research
• ☆ Cancer Biology
• ☆ Research
• ☆ Peer Review
• ☆ Technical & Scientific Writing

サービス

• Writing
• Research

Writing Clinical Trial Documentation, Technical Writing, Newswriting

Research Systematic Literature Review, Secondary Data Collection

職務経験

Head of Department for genetic counseling and hereditary cancers

Institute for Oncology and Radiology of Serbia

1月 2019 - 現在

Assistant Research Professor

Institute for Oncology and Radiology of Serbia

1月 2014 - 現在

学歴

Master of Science in Bioethics

Clarkson University and Mount Sinai Hospital, Department of Bioethics, Schenectady, NY 12308, USA

1月 2014 - 1月 2017

PhD in Genetics

School of Biology, University of Belgrade, Serbia

1月 2009 - 1月 2014

Master of Science in Molecular Biology and Physiology

School of Biology, University of Belgrade, Serbia

1月 2003 - 1月 2009

認定資格

• 認定資格の詳細は未入力です。

出版物

JOURNAL ARTICLE

Jakovljević, K., Matić, I.Z., Stanojković, T., Krivokuća, A., Marković, V., Joksović, M.D., Mihailović, N., Nićiforović, M., Joksović, L.(2017). Synthesis, antioxidant and antiproliferative activities of 1,3,4-thiadiazoles derived from phenolic acids . Bioorganic and Medicinal Chemistry Letters. 27. (16). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 3709-3715.

Krivokuca, A., Dragos, V.S., Stamatovic, L., Blatnik, A., Boljevic, I., Stegel, V., Rakobradovic, J., Skerl, P., Jovandic, S., Krajc, M., et al.(2017). Novel BRCA1 splice-site mutation in ovarian cancer patients of Slavic origin . Familial Cancer. Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 1-7.

Cavic, M., Krivokuca, A., Boljevic, I., Brotto, K., Jovanovic, K., Tanic, M., Filipovic, L., Zee, M., Malisic, E., Jankovic, R., et al.(2016). Pharmacogenetics in cancer therapy - 8 years of experience at the Institute for Oncology and Radiology of Serbia . Journal of B.U.ON. 21. (5). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 1287-1295.

Krivokuca, A.M., Cavic, M.R., Malisic, E.J., Rakobradovic, J.D., Kolarevic-Ivankovic, D., Tomasevic, Z.I., Brankovic-Magic, M.V.(2016). Polymorphisms in cancer susceptibility genes XRCC1, RAD51 and TP53 and the risk of breast cancer in Serbian women . International Journal of Biological Markers. 31. (3). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString e258-e263.

Malisic, E.J., Krivokuca, A.M., Boljevic, I.Z., Jankovic, R.N.(2015). Impact of RAD51 G135C and XRCC1 Arg399Gln polymorphisms on ovarian carcinoma risk in Serbian women . Cancer Biomarkers. 15. (5). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 685-691.

Krivokuca, A., Yanowski, K., Rakobradovic, J., Benitez, J., Brankovic-Magic, M.(2015). RAD51C mutation screening in high-risk patients from Serbian hereditary breast/ovarian cancer families . Cancer biomarkers : section A of Disease markers. 15. (6). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 775-781.

Zec, M., Srdić-Rajić, T., Krivokuća, A., Janković, R., Todorović, T., Andelković, K., Radulović, S.(2014). Novel selenosemicarbazone metal complexes exert anti-tumor effect via alternative, caspase-independent Necroptotic cell death . Medicinal Chemistry. 10. (8). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 759-771.

Krivokuca, A.M., Malisic, E.J., Dobricic, J.D., Brotto, K.V., Cavic, M.R., Jankovic, R.N., Tomasevic, Z.I., Brankovic-Magic, M.V.(2014). RAD51 135G>C and TP53 Arg72Pro polymorphisms and susceptibility to breast cancer in Serbian women . Familial Cancer. 13. (2). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 173-180.

Cavic, M., Krivokuca, A., Spasic, J., Brotto, K., Malisic, E., Radosavljevic, D., Radulovic, S., Jankovic, R.(2014). The influence of methylenetetrahydrofolate reductase and thymidylate synthetase gene polymorphisms on lung adenocarcinoma occurrence . Journal of B.U.ON. 19. (4). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 1024-1028.

Malisic, E., Brotto, K., Krivokuca, A., Cavic, M., Malisic, E., Brotto, K., Krivokuca, A., Cavic, M., Jankovic, R.(2014). Overall human papilloma virus and types 16/18 prevalence in women with normal cervical cytology in Serbia: Is it time for human papillomavirus testing and/or vaccination? . Journal of B.U.ON. 19. (4). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 973-979.

Dobričić, J., Krivokuća, A., Brotto, K., Mališić, E., Radulović, S., Branković-Magić, M.(2013). Serbian high-risk families: Extensive results on BRCA mutation spectra and frequency . Journal of Human Genetics. 58. (8). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 501-507.

Filipovic, L., Arandelovic, S., Gligorijevic, N., Krivokuca, A., Jankovic, R., Srdic-Rajic, T., Rakic, G., Tesic, Z., Radulovic, S.(2013). Biological evaluation of transdichloridoplatinum(II) complexes with 3-and 4-acetylpyridine in comparison to cisplatin . Radiology and Oncology. 47. (4). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 346-357.

Krivokuca, A., Dobricic, J., Brankovic-Magic, M.(2013). CHEK2 1100delC and Del5395bp mutations in BRCA-negative individuals from Serbian hereditary breast and ovarian cancer families . Journal of B.U.ON. 18. (3). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 594-600.

Brotto, K., Malisic, E., Cavic, M., Krivokuca, A., Jankovic, R.(2013). The usability of allele-specific PCR and reverse-hybridization assays for KRAS genotyping in serbian colorectal cancer patients . Digestive Diseases and Sciences. 58. (4). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 998-1003.

Jakovljevic, K., Malisic, E., Cavic, M., Krivokuca, A., Dobricic, J., Jankovic, R.(2012). KRAS and BRAF mutations in Serbian patients with colorectal cancer . Journal of B.U.ON. 17. (3). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 575-580.

Branković-Magić, M., Dobričić, J., Krivokuća, A.(2012). Genetics of breast cancer: Contribution of BRCA1/2 genes alterations to hereditary predisposition | Genetika karcinoma dojke: Alteracije BRCA1/2 gena i njihov doprinos naslednoj predispoziciji . Vojnosanitetski Pregled. 69. (8). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 700-706.

Jakovljević, K.V., Spasić, M.R., Mališić, E.J., Dobričić, J.D., Krivokuća, A.M., Janković, R.N.(2010). Comparison of phenol-based and alternative RNA isolation methods for gene expression analyses . Journal of the Serbian Chemical Society. 75. (8). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 1053-1061.